# New York Blood Center Enterprises - Inspection Records Source: https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db > Inspection records and compliance data for New York Blood Center Enterprises in Long Island City, New York. Access full analysis and detailed observations. --- ## Details - Name: New York Blood Center Enterprises - FEI Number: 2473015 - City: Long Island City - State: New York - Country Name: United States - Address Line 1: 4501 Vernon Blvd - Zip Code: 11101 ## Related Documents - [483 - New York Blood Center Enterprises - Unknown Date](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/eed1c575-459e-4f2d-b827-52aeb89623d1) — source: FDA, date: Invalid Date - [483 - New York Blood Center Enterprises - 2026-04-03](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/5c23488f-946d-4bc2-81bf-230ed61f964f) — source: FDA, date: April 3, 2026 - [FDA Inspection 1311062 - New York Blood Center Enterprises - 2026-04-03](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/044a9fd6-4493-4d21-a1cf-9c768fb3add1) — source: FDA, date: April 3, 2026 - [FDA Inspection 1283668 - New York Blood Center Enterprises - 2025-09-24](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/91ecba89-ae8a-4854-a2eb-f3ceac565d66) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2025 - [FDA Inspection 1217513 - New York Blood Center Enterprises - 2023-09-07](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/c705a6ed-1f5c-44af-afd1-f42b0bc46779) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023 - [FDA Inspection 1217513 - New York Blood Center Enterprises - 2023-09-07](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/47b41b89-58c5-4997-8124-42cebc55bddf) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023 - [483 - New York Blood Center Enterprises - 2020-02-11](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/3e5035ef-b0ef-43ea-b48b-39547a2005ad) — source: FDA, date: February 11, 2020 - [FDA Inspection 1118178 - New York Blood Center Enterprises - 2020-02-11](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/d7c05152-a755-44b7-acb6-8b9840cbb679) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2020 - [FDA Inspection 1036848 - New York Blood Center Enterprises - 2017-11-22](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/c5d0fa69-163e-462a-83c2-e34a55cd287b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2017 - [483 - New York Blood Center Enterprises - 2017-09-29](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/89e4ed87-8aee-4226-bc00-c4c265fec5a4) — source: FDA, date: September 29, 2017 - [FDA Inspection 1027270 - New York Blood Center Enterprises - 2017-09-29](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/019b559d-7299-43c7-bebb-75f4f7aae907) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2017 - [FDA Inspection 945089 - New York Blood Center Enterprises - 2015-09-30](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/b0dbe26c-0ead-42e8-af81-3d11ba9acb49) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2015 - [FDA Inspection 824620 - New York Blood Center Enterprises - 2013-05-07](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/6eda6dfb-9267-4f31-82f8-6dabd55adb29) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 7, 2013 - [FDA Inspection 840106 - New York Blood Center Enterprises - 2013-04-08](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/3076d9f2-fb77-44d6-8014-414b9cc0d528) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 8, 2013 ## Related Companies - [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2) - [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc) - [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa) - [Vericel Corporation](https://www.keypedia.com/companies/vericel-corporation/1955c523-5115-491b-a705-2c526deb9ff6) - [Anhui Poly Pharm. Co., Ltd.](https://www.keypedia.com/companies/anhui-poly-pharm-co-ltd/e1d9c61f-37b4-4759-8c00-51c6d0b78d3b) - [Advanced Accelerator Applications (Italy) srl](https://www.keypedia.com/companies/advanced-accelerator-applications-italy-srl/09ac059c-6735-4082-8674-a88476dbdbc6) - [AgroChem USA, LLC](https://www.keypedia.com/companies/agrochem-usa-llc/007b3455-bf3c-4d23-b1e7-0be79ebba21e) - [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3) - [OMRIX Biopharmaceuticals LTD](https://www.keypedia.com/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d) - [Pharmacia & Upjohn Company LLC](https://www.keypedia.com/companies/pharmacia-upjohn-company-llc/de0a9227-069b-44f4-a9b3-21db78c27480) ## Related Officers - [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f) - [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8) - [Investigator](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)